In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...
Speaking about obesity and diabetes, RFK Jr. said he would rather provide people with organic food three times a day than ...
Over 35 years after the first study linking the artificial food dye Red 3 to thyroid cancer in rats was published, the U.S.
President Donald Trump’s early action on health care reversed some of his predecessor’s policies, but former President Joe ...
The final proposed model would have had Medicare pay less for drugs that receive accelerated approvals from the Food and Drug ...
President Donald Trump is pulling the U.S. out of the World Health Organization, raising concerns about the U.N. agency's ...
Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind the schedule he announced ...
Novo Nordisk, which has filed a lawsuit against the Biden administration for including its insulin medications NovoLog and ...
Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback